VANCOUVER, BC / ACCESSWIRE / November 22, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that that it has commenced trading on the OTCQB Marketplace under the symbol “CRRVF” and its common shares have also been accepted for continuous trading on the electronic trading platform XETRA® on the Frankfurt Exchange under the ticker symbol B3BN.
CVR Medical CEO Peter Bakema commented: “We are pleased to now be listed on both the OTCQB Marketplace and the Frankfurt Exchange. CVR Medical will now be trading on three international platforms: TSX Venture (Canada), OTCQB (USA) and the Xetra Platform (Germany). Given the astronomical benefits that our Carotid Stenotic Scan medical device will bring to the entire healthcare system, we believe these listings will create greater visibility with US and German investors and these multiple listings/quotation platforms will allow for a much larger potential shareholder base and enhanced liquidity.”
Trading on the OTCQB does not involve the issuance of new common shares of the Corporation nor any other securities. The common shares of the Corporation that are currently issued and outstanding, and trading on the Toronto Venture Exchange, may now also be traded through the OTCQB.
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.